The Valens Company Inc. - stock earnings
Stock symbol VLNS is outdated, potentially delisted? Maybe it is available on other exchange?
VLNS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -27.5 million USD | 20.3 million USD |
| 2022Q2 | -160.8 million USD | 24.0 million USD |
| 2022Q1 | -25.7 million USD | 23.2 million USD |
| 2021Q4 | -21.4 million USD | 18.4 million USD |
| 2021Q3 | -12.8 million CAD | 21.0 million CAD |
| 2021Q2 | -8.7 million CAD | 18.8 million CAD |
| 2021Q1 | -6.2 million CAD | 20.0 million CAD |
| 2020Q4 | -16.6 million CAD | 16.0 million CAD |
VLNS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -49.0 million USD | 78.2 million USD |
| 2020 | -20.7 million USD | 83.8 million USD |
| 2019 | -6.5 million USD | 58.1 million USD |
| 2018 | -15.9 million USD | 52000 USD |
| 2017 | -4.4 million CAD | 40724 CAD |
VLNS
Price: $0.76
52 week price:
Earnings Per Share: -0.25 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 63727
Market Capitalization: 61.4 million